- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00884806
7-Day, Multi-Site Study of an Investigational Multi-Purpose Disinfecting Solution for Contact Lens Wearers
March 21, 2012 updated by: Alcon Research
Corneal Staining Evaluation of SiH MPDS FID 114675A
The purpose of this study is to clinically evaluate solution-related corneal staining with an investigational multi-purpose disinfecting solution (MPDS) in hydrogel and silicone hydrogel contact lens wearers.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older.
- Wear contact lenses a minimum of 8 hours per day for at least 7-10 days prior to Visit 1 (screening visit).
- Vision correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses at Visit 1.
- Must discontinue contact lens wear for at least two consecutive days before Visit 2 (baseline visit).
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any medical condition (systemic or ophthalmic) that may, in the opinion of the investigator, preclude safe administration of test article or safe participation in the study.
- Known sensitivity or intolerance to any protocol-specified contact lens solutions, eye drops, or products containing similar ingredients (e.g., generic products).
- Monocular vision (only one eye with functional vision) or fit with only one contact lens.
- Use of topical ocular over-the-counter or prescribed topical ocular medication, with the exception of rewetting drops, within 7 days prior to screening visit.
- Current or history of ocular infection, inflammation, disease, structural abnormality or conditions within the last 6 months that could affect study participation or may preclude safe administration of the investigational lens care solution, in the opinion of the investigator.
- Any corneal surgery, cataract surgery, intraocular lens implants or glaucoma filtering surgery within the last 12 months.
- Any slit-lamp finding score of 1 (or rated 3 or 4 for limbal and bulbar conjunctival injection) at screening or baseline visits.
- Corneal staining area assessment ≥ 20% in any corneal region in either eye at baseline visit.
- Corneal staining graded as 2 (macropunctate) or greater in any corneal region in either eye at baseline visit.
- Participation in any investigational clinical study within 30 days of baseline visit.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: FID 114675A
FID 114675A used for 7 days, per protocol-specified instructions.
Silicone hydrogel or hydrogel contact lenses worn bilaterally on a daily wear basis, one brand only.
|
Investigational solution intended for use as a cleaning, rinsing, conditioning, disinfecting, and storage solution for silicone hydrogel (SiH) contact lenses
Commercially marketed hydrogel contact lens for daily wear use
Other Names:
Commercially marketed silicone hydrogel contact lens for daily wear use
Other Names:
Commercially marketed silicone hydrogel contact lens for daily wear use
Other Names:
Commercially marketed silicone hydrogel contact lens for daily wear use
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Solution-Related Corneal Staining
Time Frame: Day 7
|
Corneal staining was assessed by the investigator using fluorescein dye, a yellow filter, and a slit lamp.
Corneal staining was graded on a continuous scale of 0% (no staining in the region) to 100% (staining covers entire region) in 1% increments for 5 corneal regions (central, nasal, temporal, inferior, and superior).
Solution-related corneal staining was defined as ≥20% corneal staining area in at least 3 corneal regions of both eyes.
|
Day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Lens Comfort
Time Frame: Day 7
|
Lens comfort was assessed by the participant on a 5-point Likert scale prior to any examination.
The participant was instructed to select a single response to the statement, "Over the previous 2-3 hours, my lenses felt comfortable," with 1 = strongly disagree, 2 = disagree, 3 = undecided, 4 = agree, and 5 = strongly agree.
|
Day 7
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
April 17, 2009
First Submitted That Met QC Criteria
April 20, 2009
First Posted (Estimate)
April 21, 2009
Study Record Updates
Last Update Posted (Estimate)
March 27, 2012
Last Update Submitted That Met QC Criteria
March 21, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- C-08-081
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lens Care
-
Southern California College of Optometry at Marshall...Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact Lens CareUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedEvaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact LensesContact Lens CareUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact Lens CareUnited States
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Ohio State UniversityAlcon ResearchCompleted
Clinical Trials on FID 114675A Multi-Purpose Disinfecting Solution (MPDS)
-
Alcon ResearchCompletedSymptomatic Contact Lens WearersUnited States
-
Alcon ResearchCompletedMyopia | Contact Lens Fit
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact Lens MoistureUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedHealthy Contact Lens WearersUnited States
-
Alcon ResearchCompletedEvaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact LensesContact Lens CareUnited States
-
Alcon ResearchCompletedContact Lens CareUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact Lens CareUnited States